Results 11 to 20 of about 2,254 (197)
The aim of this study was to report the outcome of topical brinzolamide 1% treatment on macular cystoid lesions resembling retinoschisis in 4 patients diagnosed with posterior microphthalmia. The medical records of 4 patients with a clinical diagnosis of
Ceren Durmaz Engin +3 more
doaj +3 more sources
Henny JM Beckers, Jan SAG Schouten, Carroll AB WebersUniversity Eye Clinic, Maastricht, The NetherlandsAbstract: Brinzolamide 1%/timolol 0.5% is a new fixed-combination for the treatment of open-angle glaucoma or ocular hypertension. Brinzolamide/timolol
Henny JM Beckers +2 more
doaj +1 more source
Michele IesterClinica Oculistica, University of Genoa, ItalyAbstract: Brinzolamide is a white powder commercially formulated as a 1% ophthalmic suspension to reduce intraocular pressure (IOP).
Michele Iester
doaj +2 more sources
Makoto Ishikawa1,2, Takeshi Yoshitomi11Department of Ophthalmology, Akita University Faculty of Medicine, Akita, Japan; 2Department of Ophthalmology, Ogachi Central Hospital, Akita, JapanPurpose: To study the effect of the concomitant use of brinzolamide
Makoto Ishikawa, Takeshi Yoshitomi
doaj +1 more source
PurposeThe purpose of this study was to investigate the effect of a 1% brinzolamide and 0.1% brimonidine fixed combination (BBFC) on ONH blood flow (BF) in rabbits.MethodsA crossover study was conducted on pigmented rabbits; a physiological saline ...
Nana Takahashi +5 more
doaj +2 more sources
Katrin Lorenz1, Klaus Rosbach2, Andreas Matt3, Norbert Pfeiffer11University Medical Center, Johannes Gutenberg-Universität Mainz, Mainz, Germany; 2Private practice, Mainz, Germany; 3Private practice, Köln-Hohenhaus, GermanyBackground ...
Lorenz K, Rosbach K, Matt A, Pfeiffer N
doaj +1 more source
Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
Objectives:To investigate the intraocular pressure (IOP)-lowering efficacy, safety, and treatment tolerability of brinzolamide/ brimonidine fixed combination (BBFC) in maximum medical therapy.Materials and Methods:The medical records of 92 patients with ...
Oya Tekeli, Helin Ceren Köse
doaj +2 more sources
AIM: To evaluate the effect of brinzolamide-timolol fixed combination on intraocular pressure (IOP) after cataract surgery.METHODS:The study included 92 eyes of 87 patients who underwent cataract surgery and intraocular lens implantation.
Kemal Örnek +5 more
doaj +2 more sources
Adjunctive therapy with brinzolamide in patients on travoprost treatment
Introduction. This study was aimed at evaluating the safety and efficacy of brinzolamide 1% suspension (Azopt? 1%) and travoprost 0.004% (Travatan?) combined therapy in patients with open-angle glaucoma or ocular hypertension who are in need of additional intraocular pressure lowering. Material and methods.
Nikola Babic +4 more
openaire +4 more sources
Brinzolamide-timolol suspension: acceptability and side effect profile
MD Doherty, SG Fraser, PS PhelanSunderland Eye Infirmary, Sunderland, Tyne and Wear, UKBackground: This study aimed to determine the frequency, nature, and impact of side effects associated with the use of brinzolamide-timolol suspension, a topical ...
Doherty MD, Fraser SG, Phelan PS
doaj +1 more source

